Collaborative Decision-Making for Extended Endocrine Therapy in Early-Stage, HR+ Breast Cancer

Linda Moors, PA-C* partnered with her patient Cheryl to make important decisions regarding her breast cancer treatment. When it came to making a decision about extended endocrine therapy, they both knew the Breast Cancer Index® Test would help give Cheryl the personalized answers she wanted.

*Linda Moors, PA-C is a consultant of Biotheranostics, Inc. Statements reflect the speakers’ own personal views and interpretations.